Product
Modified GCN+TTF
1 clinical trial
3 indications
Indication
Pancreatic CancerIndication
Pancreatic adenocarcinomaIndication
Metastatic AdenocarcinomaClinical trial
A Phase I/Ib Pilot Trial, Single Arm, Open Label, of Protein-Bound Paclitaxel, Cisplatin, and Gemcitabine (GCN) Combined With Tumor Treatment Fields (TTF) in Patient With Metastatic Pancreatic AdenocarcinomaStatus: Recruiting, Estimated PCD: 2025-03-01